Dubey S - Search Results

1

Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.

Wakelee H, Dubey S, Gandara D. Wakelee H, et al. Among authors: dubey s. Oncologist. 2007 Mar;12(3):331-7. doi: 10.1634/theoncologist.12-3-331. Oncologist. 2007. PMID: 17405898 Free article. Review.

2

Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond.

Dubey S, Siegfried JM, Traynor AM. Dubey S, et al. Lancet Oncol. 2006 May;7(5):416-24. doi: 10.1016/S1470-2045(06)70693-3. Lancet Oncol. 2006. PMID: 16648046 Review.

3

EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer.

Dubey S, Stephenson P, Levy DE, Miller JA, Keller SM, Schiller JH, Johnson DH, Kolesar JM; Eastern Cooperative Oncology Group. Dubey S, et al. J Thorac Oncol. 2006 Jun;1(5):406-12. J Thorac Oncol. 2006. PMID: 17409891 Free article. Clinical Trial.

4

Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.

Dubey S, Schiller JH. Dubey S, et al. Oncologist. 2005 Apr;10(4):282-91. doi: 10.1634/theoncologist.10-4-282. Oncologist. 2005. PMID: 15821248 Free article. Review.

5

Update in lung cancer 2006.

Dubey S, Powell CA. Dubey S, et al. Am J Respir Crit Care Med. 2007 May 1;175(9):868-74. doi: 10.1164/rccm.200702-190UP. Am J Respir Crit Care Med. 2007. PMID: 17446343 Free PMC article. Review. No abstract available.

6

Update in lung cancer 2008.

Dubey S, Powell CA. Dubey S, et al. Am J Respir Crit Care Med. 2009 May 15;179(10):860-8. doi: 10.1164/rccm.200902-0289UP. Am J Respir Crit Care Med. 2009. PMID: 19423719 Free PMC article. Review. No abstract available.

7

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Traynor AM, Schiller JH, Stabile LP, Kolesar JM, Eickhoff JC, Dacic S, Hoang T, Dubey S, Marcotte SM, Siegfried JM. Traynor AM, et al. Among authors: dubey s. Lung Cancer. 2009 Apr;64(1):51-9. doi: 10.1016/j.lungcan.2008.07.002. Epub 2008 Aug 12. Lung Cancer. 2009. PMID: 18701186 Free PMC article.

8

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.

Glisson B, Besse B, Dols MC, Dubey S, Schupp M, Jain R, Jiang Y, Menon H, Nackaerts K, Orlov S, Paz-Ares L, Ramlau R, Tang R, Zhang Y, Zhu M. Glisson B, et al. Among authors: dubey s. Clin Lung Cancer. 2017 Nov;18(6):615-625.e8. doi: 10.1016/j.cllc.2017.05.007. Epub 2017 May 10. Clin Lung Cancer. 2017. PMID: 28601388 Clinical Trial.

9

Chemotherapy for advanced non-small cell lung cancer.

Dubey S, Schiller JH. Dubey S, et al. Hematol Oncol Clin North Am. 2004 Feb;18(1):101-14. doi: 10.1016/s0889-8588(03)00135-7. Hematol Oncol Clin North Am. 2004. PMID: 15005284 Review.

10

ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.

Gewanter RM, Rosenzweig KE, Chang JY, Decker R, Dubey S, Kong FM, Lally BE, Langer CJ, Lee HK, Movsas B. Gewanter RM, et al. Among authors: dubey s. Curr Probl Cancer. 2010 May-Jun;34(3):228-49. doi: 10.1016/j.currproblcancer.2010.04.001. Curr Probl Cancer. 2010. PMID: 20541060 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,573 results

Search Page

Filters